We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.15B
1-Year Est. Return 13.14%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+13.14%
3 Year Est. Return
+63.19%
5 Year Est. Return
+70.18%
10 Year Est. Return
+417.82%
AUM
$9.98B
AUM Growth
+$1.09B
Cap. Flow
+$323M
Cap. Flow %
3.24%
Top 10 Hldgs %
71.22%
Holding
97
New
4
Increased
29
Reduced
16
Closed
3

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$134M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$34.7M
3
IBN icon
ICICI Bank
IBN
+$21.1M
4
V icon
Visa
V
+$19.4M
5
IRTC icon
iRhythm Holdings
IRTC
+$18.2M

Top Sells

Rank Stock Value
1
HDB icon
HDFC Bank
HDB
+$19.8M
2
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$15.9M
3
EXAS
Exact Sciences
EXAS
+$11.5M
4
SE icon
Sea Limited
SE
+$11.4M
5
NVCR icon
NovoCure
NVCR
+$10.9M

Sector Composition

Rank Sector Weight
1 Financials 22.76%
2 Consumer Discretionary 17.07%
3 Healthcare 16.6%
4 Consumer Staples 10.48%
5 Technology 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
51
Insmed
INSM
$28.3B
$12.8M 0.13%
383,110
-60,000
-14% -$2.19M
KRYS icon
52
Krystal Biotech
KRYS
$10.3B
$11.1M 0.11%
185,809
– –
GWPH
53
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$10.8M 0.11%
93,473
– –
TVRD
54
Tvardi Therapeutics
TVRD
$24.9M
$10.6M 0.11%
19,541
– –
VCRA
55
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$9.55M 0.1%
230,058
-25,000
-10% -$857K
KPTI icon
56
Karyopharm Therapeutics
KPTI
$36.5M
$9.29M 0.09%
+40,000
New +$9.27M
INFY icon
57
Infosys
INFY
$44.8B
$8.9M 0.09%
525,041
+292,863
+126% +$4.48M
TDOC icon
58
Teladoc Health
TDOC
$1.12B
$8M 0.08%
+40,000
New +$8.13M
TXMD icon
59
TherapeuticsMD
TXMD
$25M
$7.49M 0.08%
123,797
– –
GPN icon
60
Global Payments
GPN
$23.4B
$5.76M 0.06%
26,749
– –
SNPS icon
61
Synopsys
SNPS
$76.2B
$5.06M 0.05%
19,518
– –
COO icon
62
Cooper Companies
COO
$10.3B
$4.97M 0.05%
54,716
– –
DBX icon
63
Dropbox
DBX
$7.73B
$4.78M 0.05%
215,425
– –
WAT icon
64
Waters Corp
WAT
$40.1B
$4.59M 0.05%
18,549
– –
MELI icon
65
Mercado Libre
MELI
$96.2B
$4.54M 0.05%
2,711
+124
+5% +$175K
XYL icon
66
Xylem
XYL
$25B
$4.53M 0.05%
44,476
– –
AOS icon
67
A.O. Smith
AOS
$7.8B
$4.17M 0.04%
76,158
– –
RMD icon
68
ResMed
RMD
$31.5B
$4.09M 0.04%
19,247
– –
EA
69
DELISTED
Electronic Arts
EA
$4.08M 0.04%
28,381
– –
AXDX
70
DELISTED
Accelerate Diagnostics
AXDX
$3.98M 0.04%
52,468
– –
CGNX icon
71
Cognex
CGNX
$10.8B
$3.93M 0.04%
48,912
– –
PTC icon
72
PTC
PTC
$14.2B
$3.87M 0.04%
32,323
– –
ALLE icon
73
Allegion
ALLE
$13B
$3.68M 0.04%
31,615
– –
MSCI icon
74
MSCI
MSCI
$40.3B
$3.01M 0.03%
6,732
– –
MKC icon
75
McCormick & Company Non-Voting
MKC
$13.8B
$2.83M 0.03%
29,626
– –
1 2
3
4

Similar funds

MSI
Mitsui Sumitomo Insurance Tokyo, Japan $4.15B AUM
LWCA
Locust Wood Capital Advisers New York $4.15B AUM 31.06% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
JFG
JMG Financial Group Downers Grove, Illinois $4.14B AUM 21.49% 1-Year Est. Return
CCMIC
Cardinal Capital Management Inc (Canada) Winnipeg, Manitoba, Canada $4.13B AUM 31.23% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
FMII
Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

C WorldWide Group's Q4 2020 Portfolio in Review

As of Q4 2020, C WorldWide Group held 97 positions worth $9.98B, up 12% from $8.89B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

C WorldWide Group deployed $323M of net new capital in Q4 2020, opening 4 new positions and adding to 29 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 466,544 shares worth $34.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was HDFC Bank, an estimated $19.8M trimmed.

  • C WorldWide Group's largest Q4 2020 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 466,544 shares worth $34.1M.
  • C WorldWide Group added most to S&P Global in Q4 2020, an estimated $134M increase.
  • C WorldWide Group's biggest Q4 2020 reduction was HDFC Bank, cutting an estimated $19.8M.
  • C WorldWide Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $15.9M.
  • C WorldWide Group's ten largest holdings make up 71% of its $9.98B portfolio in Q4 2020.
  • C WorldWide Group opened 4 new positions and closed 3 in Q4 2020.
  • C WorldWide Group's portfolio value rose 12% quarter-over-quarter to $9.98B.

Based on C WorldWide Group's 13F filing for Q4 2020, filed 5 Feb 2021.